Login / Signup

Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.

Asad Farooq DurraniBita MomenaeiTaku WakabayashiSudheshna VemulaSaagar A PanditJason HsuAllen C HoMarc J SpirnMichael A KlufasSunir J GargJames F VanderCarl D RegilloAllen ChiangAjay E KuriyanYoshihiro Yonekawa
Published in: The British journal of ophthalmology (2024)
Intravitreal faricimab can improve anatomic outcomes while maintaining visual acuity in eyes with pDME previously treated with anti-VEGF therapy.
Keyphrases
  • vascular endothelial growth factor
  • optical coherence tomography
  • endothelial cells
  • type diabetes
  • diabetic retinopathy
  • cataract surgery
  • stem cells
  • metabolic syndrome
  • insulin resistance
  • glycemic control